Benitec Biopharma Inc
NASDAQ:BNTC
Income Statement
Earnings Waterfall
Benitec Biopharma Inc
Income Statement
Benitec Biopharma Inc
| Mar-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||
| Revenue |
2
N/A
|
6
+199%
|
6
+0%
|
7
+16%
|
8
+14%
|
4
-47%
|
5
+18%
|
3
-38%
|
4
+11%
|
0
-99%
|
0
+267%
|
0
+27%
|
0
-29%
|
0
+30%
|
0
-62%
|
0
-60%
|
0
+200%
|
0
N/A
|
0
N/A
|
0
+167%
|
0
-13%
|
0
+14%
|
0
-25%
|
0
N/A
|
0
+33%
|
0
-13%
|
0
-14%
|
0
-83%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
2
N/A
|
6
+203%
|
6
0%
|
7
+14%
|
8
+14%
|
4
-48%
|
5
+17%
|
3
-40%
|
3
+8%
|
0
-100%
|
0
+3 800%
|
0
-5%
|
0
-22%
|
0
-31%
|
(0)
N/A
|
(0)
+6%
|
(0)
+60%
|
0
N/A
|
0
+100%
|
0
+300%
|
0
-25%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+33%
|
0
-1%
|
0
+3%
|
0
N/A
|
0
-98%
|
0
+50%
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||
| Operating Expenses |
(13)
|
(10)
|
(9)
|
(9)
|
(12)
|
(10)
|
(10)
|
(10)
|
(12)
|
(1)
|
(4)
|
(6)
|
(9)
|
(10)
|
(11)
|
(12)
|
(14)
|
(16)
|
(17)
|
(17)
|
(18)
|
(18)
|
(18)
|
(19)
|
(19)
|
(21)
|
(22)
|
(22)
|
(23)
|
(22)
|
(24)
|
(30)
|
(42)
|
(45)
|
|
| Selling, General & Administrative |
(6)
|
(5)
|
(4)
|
(5)
|
(7)
|
(6)
|
(6)
|
(6)
|
(7)
|
(1)
|
(3)
|
(4)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(8)
|
(9)
|
(14)
|
(23)
|
(31)
|
|
| Research & Development |
(7)
|
(5)
|
(4)
|
(4)
|
(5)
|
(4)
|
(4)
|
(4)
|
(5)
|
(0)
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(7)
|
(7)
|
(9)
|
(11)
|
(10)
|
(11)
|
(11)
|
(12)
|
(13)
|
(13)
|
(15)
|
(16)
|
(15)
|
(16)
|
(15)
|
(15)
|
(16)
|
(18)
|
(27)
|
|
| Depreciation & Amortization |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
|
| Operating Income |
(10)
N/A
|
(4)
+66%
|
(3)
+28%
|
(1)
+42%
|
(4)
-176%
|
(6)
-43%
|
(5)
+10%
|
(7)
-43%
|
(9)
-20%
|
(1)
+87%
|
(3)
-180%
|
(5)
-64%
|
(8)
-54%
|
(10)
-18%
|
(11)
-12%
|
(13)
-15%
|
(14)
-8%
|
(16)
-16%
|
(17)
-10%
|
(17)
+2%
|
(18)
-5%
|
(18)
+1%
|
(18)
-4%
|
(19)
-5%
|
(19)
+1%
|
(20)
-7%
|
(22)
-6%
|
(21)
+1%
|
(22)
-5%
|
(22)
+0%
|
(24)
-8%
|
(30)
-25%
|
(42)
-39%
|
(45)
-8%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||
| Interest Income Expense |
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
2
|
2
|
3
|
3
|
3
|
|
| Non-Reccuring Items |
(1)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(11)
N/A
|
(5)
+60%
|
(3)
+38%
|
(2)
+41%
|
(4)
-158%
|
(6)
-39%
|
(6)
+6%
|
(8)
-37%
|
(9)
-17%
|
(1)
+87%
|
(3)
-182%
|
(5)
-65%
|
(8)
-55%
|
(10)
-19%
|
(11)
-12%
|
(13)
-16%
|
(14)
-8%
|
(16)
-17%
|
(18)
-10%
|
(17)
+4%
|
(18)
-6%
|
(18)
0%
|
(19)
-3%
|
(20)
-6%
|
(20)
+2%
|
(20)
-4%
|
(22)
-7%
|
(22)
+1%
|
(22)
0%
|
(21)
+4%
|
(21)
-3%
|
(26)
-24%
|
(38)
-43%
|
(42)
-10%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(11)
|
(5)
|
(3)
|
(2)
|
(4)
|
(6)
|
(6)
|
(8)
|
(9)
|
(1)
|
(3)
|
(5)
|
(8)
|
(10)
|
(11)
|
(13)
|
(14)
|
(16)
|
(18)
|
(17)
|
(18)
|
(18)
|
(19)
|
(20)
|
(20)
|
(20)
|
(22)
|
(22)
|
(22)
|
(21)
|
(21)
|
(26)
|
(38)
|
(42)
|
|
| Net Income (Common) |
(11)
N/A
|
(5)
+60%
|
(3)
+38%
|
(2)
+41%
|
(4)
-158%
|
(6)
-39%
|
(6)
+6%
|
(8)
-37%
|
(9)
-17%
|
(1)
+87%
|
(3)
-182%
|
(5)
-65%
|
(8)
-55%
|
(10)
-19%
|
(11)
-12%
|
(13)
-16%
|
(14)
-8%
|
(16)
-17%
|
(18)
-10%
|
(17)
+4%
|
(18)
-6%
|
(18)
0%
|
(19)
-3%
|
(20)
-6%
|
(20)
+2%
|
(20)
-4%
|
(22)
-7%
|
(22)
+1%
|
(22)
-3%
|
(21)
+4%
|
(22)
-3%
|
(27)
-23%
|
(38)
-40%
|
(42)
-10%
|
|
| EPS (Diluted) |
-1.31
N/A
|
-0.51
+61%
|
-0.3
+41%
|
-0.25
+17%
|
-0.62
-148%
|
-0.57
+8%
|
-0.39
+32%
|
-0.95
-144%
|
-1.09
-15%
|
-22.99
-2 009%
|
-54
-135%
|
-89
-65%
|
-137.83
-55%
|
-140.85
-2%
|
-44.08
+69%
|
-45.82
-4%
|
-55.52
-21%
|
-33.77
+39%
|
-37.04
-10%
|
-35.72
+4%
|
-37.93
-6%
|
-28.53
+25%
|
-11.63
+59%
|
-12.1
-4%
|
-14.07
-16%
|
-9.46
+33%
|
-8.46
+11%
|
-8.29
+2%
|
-5.51
+34%
|
-2.01
+64%
|
-0.99
+51%
|
-0.7
+29%
|
-1.05
-50%
|
-1
+5%
|
|